PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin
Clinical trial NCT05810870 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05810870
- Sponsor
- MedSIR
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-24
- Primary completion
- 2026-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.